About Princess Margaret Hospital Phase 2 Consortium
Clinical Trials at Princess Margaret Hospital Phase 2 Consortium
During the past decade, Princess Margaret Hospital Phase 2 Consortium conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Princess Margaret Hospital Phase 2 Consortium
According to Clinical.Site data, the most researched conditions in "Princess Margaret Hospital Phase 2 Consortium" are
"Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities" (2 trials), "Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)" (2 trials), "Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)" (2 trials), "Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)" (2 trials) and "Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)" (2 trials). Many other conditions were trialed in "Princess Margaret Hospital Phase 2 Consortium" in a lesser frequency.
Clinical Trials Intervention Types at Princess Margaret Hospital Phase 2 Consortium
Most popular intervention types in "Princess Margaret Hospital Phase 2 Consortium" are "Drug" (13 trials), "Other" (9 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "laboratory biomarker analysis" (9 trials), "pharmacological study" (4 trials), "decitabine" (2 trials), "lapatinib ditosylate" (2 trials) and "sorafenib tosylate" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Princess Margaret Hospital Phase 2 Consortium
The vast majority of trials in "Princess Margaret Hospital Phase 2 Consortium" are
12 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Princess Margaret Hospital Phase 2 Consortium
Currently, there are NaN active trials in "Princess Margaret Hospital Phase 2 Consortium".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Princess Margaret Hospital Phase 2 Consortium,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Princess Margaret Hospital Phase 2 Consortium, 3 "Phase 1"
clinical trials were conducted, 11 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".